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The Effects of ACTH on the A-3y6-Hydroxysteroid Dehydrogenase in Rabbit 
Adrenal Cortex (99 p p .)
Director: H. R. F e v o ld /^ ^ ^
5
The a c t iv i ty  o f a  -3/hydroxysteroid dehydrogenase in adrenal microsomes 
from control and ACTH-treated rabbits was measured with two substrates, pregn­
enolone and 17o^-hydroxy pregnenolone. The rate of product formation from 
labelled and nonlabelled substrates was measured. The values obtained with 
labelled and nonlabelled substrates were generally in good agreement. No 
consistent difference in the rate of progesterone formation from pregnenolone 
was observed in microsomes from control and ACTH-treated rabbits. A max­
imal rate of 23 nmol progesterone per minute per mg protein was obtained.
The substrate levels which were saturating in the pregnenolone substrate 
experiments were not saturating in the 17a-hydroxypregnenolone substrate 
experiments. The maximal rate  of product formation using 17a-hydroxypregn- 
enolone as a substrate was 90 nmol 17af-hydroxyprogesterone per minute per 
mg protein. In one 17#-hydroxypregnenolone substrate experiment in which 
only s lig h t  stimulation by ACTH was present as determined by 17oC-hydroxylase 
a c t iv i ty ,  the rates obtained in microsomes from control and ACTH-treated 
microsomes were conparable. Apparent V^ax values fo r the 34-hydroxy-
steroid dehydrogenase enzyme were 222 nmol per minute per mg protein and 
2 X lOrS, respectively. In another 17a>hydroxypregnenolone substrate experi­
ment in which greater ACTH stimulation was present, the rate of product 
formation in the microsomes from ACTH-treated rabbits was lower than the 
control at the higher substrate le v e l .  Addition of human serum increased 
the rate of product formation in microsomes from both control and ACTH- 
treated rabbits but a greater increase was observed in the microsomes from 
ACTH-treated microsomes. These resu lts  suggest that ACTH increased the 
s e n s it iv ity  of the 34-hydroxyste roid dehydrogenase enzyme to product inh ib­
i t io n .
Cytochrome P-450 levels were measured in microsomes from control and 
ACTH-treated rabbits and the levels were found to be s l ig h t ly  lower in ACTH 
microsomes indication that the cytochrome may not be a ra te - l im it in g  compo­
nent of the 17ûC-hydroxylase system.
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INTRODUCTION
Adrenal Cortex: Historical Aspects
The necessity of the adrenal for the maintenance of life 
was first discovered when Thomas Addison described a fatal dis­
ease caused by the deterioration of the gland (1). A highly 
vascularized organ the adrenal consists of two regions which 
are derived from different embryonic tissues (1). The outer 
region called the cortex originates from the lateral mesoderm, 
which is also the source of gonadal tissue, while the inner 
region or medulla develops from the neural crest cells. Unlike 
the animal whose cortex has been removed, an animal deprived 
of its medulla can survive quite well, which indicates that it 
is the cortex that is responsible for sustaining life (1).
Attempts to isolate from the adrenal gland substances which 
could prolong the lives of adrenalectomized animals failed until 
their lipid-soluble nature was discovered (2). Between I929- 
1930 three research groups, Rogoff and Sterwart, Hartman and 
Brownell, and Swingle and Pfiffer extracted a lipid-soluble 
fraction from adrenal glands which proved effective in length­
ening the lives of adrenalectomized animals (2). Kendall and 
coworkers and Reighstein and coworkers were able to isolate 
approximately thirty steroids from the adrenal, six of which 
were biologically active (2).
Structurally, these isolated steroids resembled the first
2
21 carbons of cholesterol, which pointed to a common precursor 
role for the sterol. In I918 Laignel-Lavastine had observed 
that human adrenal glands obtained at autopsy from patients 
who had died from stressful causes, such as acute infection, 
contained less cholesterol than those of patients who had died 
of less stressful causes (2). Bloch in 19^5 gave deuterium- 
labelled cholesterol to a pregnant woman and was able to iso­
late the label in pregnanediol, a known metabolite of proges­
terone (2). This indicated a precursor role for cholesterol 
in another steroid-synthesizing tissue. In 19^9 Pincus and 
Hechter perfused ^^C-labelled acetate, the initial precursor 
of cholesterol, into bovine adrenal glands and were able to 
isolate a number of radioactive steroids (2). In the perfusion 
experiments with ^^C-labelled acetate the isolated radioactve 
steroid were used as substrates in subsequent perfusions and 
a sequence of reactions leading to the formation of the most 
biologically active glucocorticoid, cortisol, was established. 
These results were confirmed by Haynes using adrenal minces 
(2j.
Smith in I925 observed the. degeneration of the adrenal 
cortex following hypophysectomy (3). He also found that fresh, 
ground pituitary tissue reversed the process of deterioration 
in hypophysectomized animals. During the years between 194-2 
and 1943 Li and associates and Sayers and associates isolated 
a corticotropic protein from the adenohypophysis (3). Later 
in the 1950*s they further purified the protein, a 39 smino acid 
polypeptide, now called adrenocorticotropic hormone or simply 
ACTH. Later Hechter and coworkers showed ACTH to be a controlling
factor in glucocorticosteroid synthesis in bovine adrenal glands 
perfused with the pituitary hormone {3)•
Glucocorticosteroidogenesis; Biosynthetic Pathways
Biosynthesis of glucocorticoids from cholesterol has been 
shown to begin with cleavage at the carbon 20-22 bond of the 
side-chain of cholesterol to form pregnenolone and isocaproic 
aldehyde (2)m The conversion outlined in Figure 1 involves 
more than one step. Kinetic studies of Burstein and Gut showed 
the sequential appearances of intermediates involved in the 
side-chain cleavage of cholesterol to form pregnenolone in bovine 
adrenocortical mitochondrial acetone-dried powder preparations 
(4). Cholesterol was first hydroxylated at the carbon 22 posi­
tion followed by a hydroxylation at the carbon 20 position. 
Pregnenolone was formed when the carbon 20-22 bond of (20R,22R)- 
20,22-dihydroxycholesterol was broken.
Pregnenolone, a -3P-hydroxysteroid, was shown to be con­
verted to a A^-3-keto steroid, progesterone {5)» Hechter and 
Pincus established a route of glucocorticoid synthesis from 
progesterone resulting in the formation of cortisol and corti­
costerone in perfused bovine adrenal glands {2). That cortisol 
and corticosterone were produced from progesterone via separate 
pathways soon became apparent. Perfusion of progesterone increased 
levels of lya-hydroxyprogesterone, cortisol and corticosterone. 
However, perfusion of l?a-hydroxyprogesterone increased cortisol 
levels only. Similarily, 11-deoxycorticosterone, an intermediate 
of glucorticoid synthesis, gave rise only to corticosterone.
No conversion of corticosterone to cortisol could be shown
CHOLESTEROL(mitochondrial)
(HADPH, Og)
(22R)-22-HYDROXYCHOLESTEROL
(NADPH, Og)
(20R,22R)-20,22-DIHYDROXYCHOLESTEROL
(NADPH, 0^)
PREGNENOLONE
+
ISOCAPROIC ALDEHYDE
ISOCAPROIC ACID
Figure 1. Mechanism of cholesterol side-chain cleavage by adrenal cortex.
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which further indicated a complete separation of pathways from 
progesterone. Figure 2 outlines the major steps in cortico­
sterone and cortisol synthesis from progesterone (6),
In 1959 Gartensen and coworkers discovered l?a-hydroxy- 
pregenenolone in adrenal, vein blood of the dog (2). The con­
version of 17a-hydroxypregnenolone to 17a-hydroxyprogesterone 
was demonstrated in canine testis in vivo (7J« Lipsett and 
Hokfelt were able to show the conversion of 17^̂-hydroxypregne- 
nolone to cortisol (8;. The pathway of cortisol production 
from pregnenolone via 17o^-hydroxyPregnenolone was demonstrated 
(9;, Shimizu in 1965 gave evidence for an alternate route of 
cortisol production from cholesterol (lOJ. He and his coworkers 
demonstrated that 20a-hydroxycholesterol could be converted to 
17a-,20d-dihydroxycholesterol in human fetal adrenal tissue.
The formation of cortisol and androstenolone from 17a-,20a- 
dihydrosycho1estero1 implicated a side-chain cleavage leading 
to 17a-hydroxypregnenolone formation. However, Burstein and 
associates could not find a conversion of cholesterol to 17a-, 
20a-dihydroxycholesterol in acetone-dried guinea pig adrenal 
preparations (11). Figure 3 shows the pathways to cortisol 
wia 17a-hydroxypregnenolone (6).
Glucocorticosteroidogenesis: Enzyme Systems
Numerous hydroxylations of the steroid ring system occur 
during synthesis of the glucocorticosteroids from cholesterol. 
All of the hydroxylase systems share five common elements:
1) they are all multi-enzyme systems; 2) they are part of organ­
elles such as the mitochondria and the microsomes; 3) the hydro-
PREGNENOLONE1PROGESTERONE
l?a-HYDROXYPROGESTERONE 11-DEOXYCORTICOSTERONE
I11-DEOXYCORTISOL CORTICOSTERONE
CORTISOL
Figure 2. Biosynthesis of cortisol and corticosterone from pregnenolone.
PREGNENOLONE
l?a-HÏDROXYPREGNENOLONE
Il?a-HYDROXYPROGESTERONE
I11-DEOXYCORTISOL1CORTISOL
Figure 3. Biosynthesis of cortisol through l?a-hydroxy- 
pregnenolone*
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xylation reactions involve the activation of molecular ozygen 
resulting in the incorporation of one atom of ozygen into the 
substrate and the other atom into v/ater; 4) NADPH is required 
as a donor of electrons for the reduction of the second mole­
cule of o ygen to water; 5) an electron transport system con­
sisting at least of a flavoprotein NADPH-cytochrome P-450 reduc­
tase and a cytochrome designated P-450 is responsible for trans­
port of electrons from IvADPH to the substrate (2).
The formation of pregnenolone from cholesterol involves 
two separate hydroxylation steps, which occur at the 20a- and 
22-carbon positions as shovm in Figure 1. Glucocorticoid syn­
thesis from pregnenolone and progesterone requires hydroxylations 
at the 113-» l?a- and 21-carbon positions. The 113-hydroxy 
group is necessary for the glucocorticoid activity of the ster­
oid (1). Hydroxylation of the 21-carbon position is also required 
for glucocorticoid activity but a steroid having only a 21-hydro­
xyl group with no 113-hydroxyl group has little influence on 
carbohydrate metabolism (1). 1?^-Hydroxylation serves to enhance
glucocorticoid activity (1).
A number of hydroxylase systems have been fractionated into 
separate protein components. A specific hydroxylation was found 
to take place only in the presence of all components. The 
enzyme system which converts cholesterol to pregnenolone has 
been separated into tv/o fractions and both were required for 
the hydroxylation steps to occur (2). Omura and associates 
purified the enzyme system for the 113-hydroxylation and succeeded 
in reconstituting the 113-hydroxylase by mixing of three protein 
fractions (12).
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In 1961 Constantopoulos and Tchen found the side-chain 
cleavage activity in adrenal tissue entirely contained in the 
mitochondria (2). The IIP-hydroxylase enzyme system is also 
completely located in the mitochondrial fraction (13) • The 
site of both I70L- and 21-hydroxylations was confirmed to be the 
smooth endoplasmic reticulum or microsomal fraction in human 
testis (14), in rat and porcine adrenal preparations (15) and 
rabbit adrenal preparations (16).
The hydroxylase or mono oxygenase reaction is shown in the 
equation below:
AH + XH^ + O2 ---------------► AOH + H^O 4. X
in which AH represents the substrate to hydroxylated, XH^ is 
the electron donor and AOH is the hydroxylated substrate (1?). 
The oxygen atom which is inserted into the substrate was found 
to be stable to exchange since hydroxylase reactions carried
18 •out in H2O show no isotope in the product (2). The irrever­
sibility of the reactions is further indicated by the large 
free energy change (greater than 90 kcal per mole) which occurs 
(2).
The electrons used for reduction of the second oxygen atom 
are furnished by NADPH through an electron transport chain (2). 
The components of the electron transport chain and their inter­
action are summarized in Figure 4 which is a modified diagram 
of Harding, Bell, Oldham and Wilson (13) » A separate branch 
of the electron transport system in microsomes involves NADH, 
NADH-dependent flavoprotein and cytochrome b^ (13) • The linkage 
between the NADPH electron transfer system and the NADH electron
10
transfer system is proposed to be a nonheme-iron protein desig­
nated "Factor X" (13)•
A component of the electron transport chain which is of 
particular interest is cytochrome P-450 an iron-porphyrin con­
taining protein. The carbon monoxide derivative of the reduced 
cytochrome absorbs maximally at 450 nm, thus the name cytochrome 
P-450. A single species of cytochrome P-450 was suggested by 
the common requirements of NADPH and molecular oxygen and the 
identical carbon monoxide-induced spectra associated with llP- 
hydroxylation and 21-hydroxylation (2). However, evidence for 
multiple forms of the cytochrome has accumulated in recent years. 
The specificity of the inhibitor metyrapone for 11^-hydroxy­
lation suggests separate cytochromes (18). Mull and associates 
resolved a cytochrome P-450 fraction from mouse liver micro­
somes into two bands using SDS-polyacrlaraide gel electrophoreses 
(19) # One band designated cytochrome P-448 was more prominent 
after 3-methylcholanthrene induction. Thomas and coworkers 
demonstrated immunological differences between cytochromes 
isolated from phenobarbitol-treated rats and 3-methylcholan- 
threne-treated rats (20). Multiple forms of cytochrome P-450 
could account for the specificity of hydroxylases.
In addition to the hydroxylases, two other general groups 
of enzymes are active in steroid-synthesizing tissues. They 
are the dehydrogenases and the isomerases (2). The dehydrog­
enases catalyzes reversible reactions which require either NAD 
or NADP for the transfer of hydrogen. The isomerases catalyze 
the movement of a double bond from one position to another and 
have no apparent coenzyme requirement.
p-450-Fe^~0,.
NADPH ^Fp
NADH ►Fp ►Cyt B,}Factor X P-450-PeP-450-Pe^"
Enzyme-
Steroid
(P-450-Pe^ -Og )1
Enzyme + HO-steroid + H^O
Figure 4. Electron transport system of hydroxylase enzymes. Fp designates 
a flavoprotein. P-450 represents cytochrome P-450.
H
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Only one type of dehdrogenase and one type of isomerase 
are important to glucocorticoid biosynthesis in the adrenal 
cortex. They are the NAD-dependent 3P"hydroxysteroid dehydro­
genase and the ^-3-ketosteroid isomerase respectively. Both 
function in the same reaction, that is, the conversion of a
3P"hydroxysteroid to a -3-ketosteroid, such as the conver­
sion of pregnenolone to progesterone or lya-hydrox^regnen- 
olone to lyu-hydroxyprogesterone. Figure 5 is a structural 
representation of these reaction and shows their order in the 
biosynthetic pathway of glucocorticoids. First demonstrated 
in mammalian tissue by Samuels and associates this conversion 
is essential to the biosynthesis of all biologically-active 
steroid hormones (5)* In the absence of the nucleotide cofac-
zltor no significant formation of A -3-ketosteroid from A “3P“ 
hydroxysteroid is observed (21). Therefore, oxidation of 
A^-3P-hydroxysteroids to A^-3”ketosteroids must proceed the 
isomerization to Z^-3-ketones. At all concentrations of sub­
strate the rate of isomerization exceeded that of dehydrogena­
tion in acetone-dried powder preparations of bovine adrenals 
(22). The dehydrogenation of the /^-3^-hydroxysteroid is then 
the rate-limiting step in this conversion.
The close association of the dehydrogenase and isomerase 
activities made them intially difficult to separate. Beyer 
and Samuels were first to describe the partial extraction of 
the dehydrogenase-isomerase system from microsomes using a 
nonionic detergent (23). Ford and Engel extracted a A^-3P- 
hydroxysteroid dehydrogenase-isomerase system from sheep adrenal
13
CHOLESTEROLHO
CH.
I ■c=o
OH
PREGNENOLONE I7t<-HYDR0XYPREGNEN0L0NE
rZc/^OHYLASE
PROGESTERONE
OH,
0 = 0 , -OH
ITô tHYDROXYPROGESTERONE
1
CH.OH
CORTICOSTERONE
I CHaOH
COETISOL
Figure 5. Conversion of ^^-3/3-hydroxysteroids tn ketosteroids by the 3/3-^ydroxysteroid dehydro­genase -isomerase system (̂ /3-RSD-I),
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cortical microsomes using Triton X-100 (24). They found that 
the dehydrogenase and the isomerase copurified to a state which 
appproached protein homogeneity. Cheaturn and coworkers solu­
bilized dehydro genase-isomerase systems from both bovine corpora 
lutea (25) and bovine adrenals (26). V/hile they could not 
accomplish complete physical separation of the dehydrogenase 
and the isomerase activities, their data indicated differences 
in activity ratios, inactivation rates and pH curves during 
purification, which indicate that activities do not occur at 
the same site. Ewald and associates fractionated bovine adrenal 
cortex homogenates and found tv;o fractions with high isomerase 
activities (2?). Dehydrogenase activity was completely absent 
in one of the fractions indicating the requirement of two enz­
ymes.
The location of A^-3P-hydroxysteroid dehydrogenase-isomer­
ase system in the microsomal fraction has been well established 
(2). Inano and associates found the enzyme complex activity 
to be associated primarily with the ribosome-free fraction of 
the microsomal compartment (2). A number of studies have shown 
that some dehydro genase-isomerase actvity is also found in the 
mitochondrial fraction (28, 29). While some researchers have 
attributed the activity in mitochondria to contamination by 
microsomes, Cov/an, Grant, Giles and Biddlecombe have demonstr­
ated dehydrogenase-isomerase activity in bovine adrenal mito­
chondria and endoplasmic reticulum which were separated by rate- 
zonal centrifugation on sucrose gradients (30).
^-3P-Hydroxysteroid dehydrogenase, the rate-limiting step
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of the A^-3P“hydroxysteroid to /^-3-keto conversion, can be 
inhibited by the products of the dehydrogenase-isomerase system. 
In human placental tissue a number of products of the reactions 
catalyzed by the enzyme complex were inhibitory at concentra­
tions low enou^ to be responsible for the lack of linearity 
observed after a few minutes in kinetic experiments (31) •
Koritz discovered that the reduced cofactor KADH was an effec­
tive inhibitor of the pregnenolone to progesterone conversion 
(32).
Much evidence has accumulated to indicate multiple enzyme 
forms of both the -3p-hydroxysteroid dehydrogenase and the
^ - 3-keto isomerase. Goldman has shown that cyanoketone, a 
specific inhibitor of 3G-hydroxysteroid dehdrogenase, inhibits 
conversion of different substrates to different extents (33) *
For instance, the pregnenolone to progesterone conversion is 
inhibited less by cyanoketone than the l?a-hydroxypregnenolone 
to lya-hydroxyprogesterone conversion. Gibb and Hagerman have 
studied the specificity of the 3P-hydroxysteroid dehydrogenase 
activity in bovine ovaries tov/ard a G-19 steroid, dehydroepi- 
andosterone, and toward pregnenolone (34). They have found 
the stereospecificity of hydride-ion transfer from pregnenolone 
to NAD ( a B transfer) differed from that of dehydroepiandro- 
sterone to NAD. Gibb and Hagerman proposed the existence of 
at least two dehydrogenases. Ewald and Associates were able 
to demonstrate the presence of three distinct isomerases in 
beef adrenal cortex (2?).
The subcellular distribution of the A^-3P-hydroxysteroid
16
dehydrogenase-isomerase system in steroid-synthesizing cells, 
the sensitivity of -33-hydroxysteroid dehydrogenase to pro­
duct inhibition and the evidence for multiple enzyme forms 
suggest a regulatory role for the enzyme complex. The effect 
of ACTH on A^-33-hydroxysteroid dehydrogenase activity, which 
is central to this thesis, will be discussed presently.
The importance of 33-hydroxysteroid dehydrogenase enzyme 
to normal adrenal function is evident in one form of congenital 
adrenal hyperplasia caused by deficiency of the enzyme (35)•
It has been demonstrated that extracts of DNA and RNA from bov­
ine adrenals significantly elevated the dehydrogenase activity 
in cyanoketone-treated rats, which were used as a model for 
the hyperplasia (36).
Figure 6 is a diagram modified from Rhodin (37) which 
summarizes the reaction sequences of glucocorticoid synthesis, 
the intracellular compartmentation of the enzymes systems and 
the relation of the cellular structures. The model was based 
in part on electron microscope studies of rat adrenal cortex 
cells.
End Product Formation; Species Variation
In 1953 Bush measured adrenal cortex secretions of cortisol 
and corticosterone in adrenal venous blood from a number of 
different species (38). The relative quantities of the two 
glucocorticoids varied from species to species but not between 
members of any one species. Sheep and monkeys were found to 
produce cortisol primarily while rats and rabbits secreted
17
SMOOTH ER 
(MICROSOMAL FRACTION)
.demofase
CHOLESTEROL
LIPID DROPLET
DEO%
MITOCHONDRION  
{ MITOCHONDRIAL FRACTION)
Figure 6. Subcellular compartmentation of enzyme 
systems» substrates and products of 
the adrenal cortex..
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corticosterone primarily. Cats dogs and ferrets secreted both 
in significant quantities. Man was reported to produce corti­
sol predominantly (39). Bush proposed that the ratio of corti­
sol to corticosterone production was genetically fixed and he 
reported that ACTH stimulation of glucocrticosteroidogenesis 
did not alter the ratio. Numerous investigators have since 
produced evidence to the contrary.
Kass, Hechter, Macchi and wou noted that ACTH, cortisone 
and cortisol had pronounced effects on the weight and ribonu­
cleic acid content of the lymph node of the rabbit, a cortico­
sterone-secreting animal (39) # However, corticosterone at the 
same dosage levels of the other two steroids had no significant 
effect on lymphatic tissue. This response of the rabbit to ACTH 
would be difficult to explain it coricosterone was being secre­
ted exclusively. Since the effect of ACTH on lymph nodes occur­
red after relatively prolonged administration, Kass and coworkers 
decided to study the pattern of corticosteroid secretion in 
the rabbit during prolonged treatment with ACTH. For 21-28 
days rabbits received 12.3-2$.0 units of porcine ACTH daily.
Under these conditions the rabbit was reported to increase cor­
tisol production dramatically while corticosterone production 
decreased, causing the cortisol/corticosterone ratio to rise 
from less than 0.01:1 to 4:1. Krum and Glen repeated the exper­
iment and observed a ratio of cortisol/corticosterone approach­
ing unity after ACTH stimulation (40). Morozova confirmed the 
findings of Kass in adrenal slices of ACTH-stimulated rabbits, 
however, his in vitro studies showed maximal cortisol production 
after only three days of stimulation (41). Using a highly
19
purified ACTH preparation Fevold demonstrated the shift in the 
pattern of adrenal secretion in rabbit adrenal gland homogenates 
and also showed a maximal cortisol production in three days 
of ACTH stimulation (42).
Alteration in Adrenal Secretory Patterns; Mechanisms of ACTH Action
In I96I Saba proposed that the effects of ACTH on adrenal 
secretion were two-fold (43). The initial effect was thought 
to be an immediate rise in the output of adrenal steroids. The 
second effect which became manifest after prolonged ACTH sti­
mulation was the alteration in ratio of adrenal products. In 
vivo and in vitro studies have indicated that the ACTH stimulates 
the conversion of cholesterol to pregnenolone (44). This effect 
was shown to be expressed within minutes. Krum and Glen have 
speculated that the effect of chronic ACTH administration must 
occur at a point in the biosynthetic pathway beyond the common 
precursor, pregnenolone (40).
Before attempting to locate the site or sites in the gluco­
corticoid biosynthetic pathway which are influenced by prolonged 
ACTH stimulation, it was necessary to determine if the struct­
ural differences of ACTH from various species were responsible 
for secretory pattern alterations. ACTH a polypeptide consist­
ing of 39 amino acids varies little in primary structure from 
one species to another (45)• Species differences seems to be 
confined to amino acid residues 25 and 33* The first twenty 
amino acids from the N-terminal can elicit some of the same 
effects as the entire ACTH molecule (45). Alteration of the 
cortisol/corticosterone ratio in rabbits was accomplished using
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T «a synthetic 3 -corticotropin(46). This result indicates that 
the variable C-terminal of the ACTH molecule is not responsible 
for the prolonged effects of the hormone. It v/as further dis­
covered that ACTH isolated from both cortisol-producing and 
corticosterone-producing species were both capable of altering 
the biosynthetic pathv/ay of the rabbit adrenal cortex (47). 
Therefore, the source of ACTH was not important to this acti­
vity of ACTH.
From their studies of ACTH effects on the secretory pro­
ducts from rabbit adrenals Krum and Glen postulated a scheme 
for glucocorticoid synthesis in rabbits which is shown in Figure 
7 and which can serve as a reference for the discussion of sites 
of ACTH action (40).
Kass and coworkers speculated that an increase in 17a- 
hydroxylation of progesterone (step d) with a decrease in the 
21-hydroxylation of progesterone to 11-deoxycorticosterone 
(step e) may be responsible for the alteration of secretion 
caused by ACTH-stimulated rabbits appears responsible for changes 
in adrenal secretory patterns. Yudaev and Morozova reported 
that a partial inhibition of 21-hydroxylase activity (step e) 
was responsible for the increase in cortisol production and 
decrease in corticosterone production (48). They found the 
activity of the 21-hydroxylase enzyme per gram of adrenal tissue 
to be twice as high in control rabbits as in ACTH-treated rab­
bits. Hov/ever, since the adrenal weights of the ACTH-treated 
animals were twice that of the control rabbits, the so-called 
inhibition may actually represent a lack of stimulation (42). 
Yudeav and Morozova had suggested that the partial inhibition
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l?a-HYDROXÏPREGNENOLONE'
CHOLESTEROL —►PREGNENOLONE -^PROGESTERONE •^17a-HÏDR0XYPR0GESTER0NE
11-DEOXYCORTICOSTERONE 17a-0H-ll-DE0XYC0RTIC0STER0NE
CORTICOSTERONE CORTISOL
Figure 7. Steroidogenesis in the rabbit adrenal cortex
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of 21-hydroxylase at step e would make more progesterone avail­
able for lya-hydroxylation step d. But, the favored substrate 
for lya-hydroxylation has been shown to be pregnenolone (step 
a) not progesterone (42).
Fevold observed that the amount of cortisol produced was 
the same whether (4-^^C)progesterone or (4-^^C)pregnenolone 
was used as a substrate, but that the specific activity of the 
cortisol formed when (4-^^C)pregnenolone was used was four times 
greater than when (4-^^C)progesterone was used as a substrate 
(42) • Slaga and Krum incubated these same precursors with 
adrenal slices and found that pregnenolone enhanced the speci­
fic activity of the l?a-hydroxycorticosteroid formed more than 
progesterone did (49). It is of interest to note that ACTH- 
stimulation in man, a cortisol-producer, increases levels of 
1?a-hydroxypregnenolone two to three times more than l?a-hydroxy- 
progesterone ($0). This may also indicate the preferential 
stimulation of the -pathway for cortisol biosynthesis.
Krum and Glen suggested that the secretory pattern-altering 
activity of prolonged ACTH stimulation may be due to a stimu­
lation at step a in Figure 7 and/or a.reduced activity at step
c. Fevold experimentally demonstrated that a stimulation of 
l?a-hydroxylase activity occurred in ACTH-stimulated tissue with 
a substrate preference for pregnenolone over progesterone (42,
51). The pregnenolone to progesterone conversion is catalyzed 
by the A^-3P-hydroxysteroid dehydrogenase-isomerase system. 
Competition between the 17^-hydroxylase and the 3P“Hydroxysteroid 
dehydrogenase-isomerase may be determining factor in endproduct 
formation. Stimulation of 17̂ -̂hydroxylation is correlated with
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increased cortisol production in ACTH-treated rabbits. An inhib­
ition of the A^-3P"Hydroxysteroid dehydrogenase may be respons­
ible for the predominance of 17 -hydroxyl at ion over progesterone 
formation from pregnenolone. However, if ACTH does inhibit
c:A -3P-hydroxysteroid dehydrogenase actvity, it might be expected 
that the l?a-hydro xypregneno lone to 17ct-hydroxyprogesterone 
conversion (step b) would not be inhibited to the same degree 
as the pregnenolone to progesterone conversion since ACTH stim­
ulates cortisol production and inhibits corticosterone production.
Haynes was the first to show that cyclic AMP (adenosine 
3*«5*“cyclic nomophosphate) levels were increased in bovine 
adrenal slices by ACTH (2). In vitro cyclic AMP has been shown 
to mimick the steroidogenic action of ACTH (2). Koritz, Yun 
and Ferguson observed that cyclic AMP inhibited the conversion 
of pregnenolone to progesterone in rat adrenals (52). McCune 
and associates showed this inhibition in both microsomal and 
mitochondrial fractions of the rat adrenal (28) while Sulimovici 
and Lunenfeld have found similar results in mouse ovarian tissue 
(53). The inhibition can be reversed by excess amounts of NAD 
(52). However, the physiological significance of cyclic AMP 
inhibition of 3P-hydroxysteroid dehydrogenase is questionable 
since nonphysiological levels of cyclic AICP are required. No 
dialyzable inhibitor of 17oc-hydroxylase could be detected in 
adrenal homogenates from ACTH-stimulated rabbits (16). A 1:1 
mixture of adrenal homogenates from control and ACTH-stimulated 
rabbits which was incubated with (4- C)pregnenolone produced 
as much 17<^-hydroxysteroid as the homogenates from ACTH-stim­
ulated adrenals (16). The same mixture of homogenates produced
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less l7-d.eoxycorticos1:eroicLs than control tissue did. In addi­
tion dialysis of both homogenates from control and ACTH-timu- 
lated rabbits showed an activation of 17-deoxycorticosteroids 
suggesting the presence of an inhibitor of 17-deoxycorticoster­
oids in ACTH-stimulated tissue.
Summary
The biosynthetic products of the adrenal cortex which are 
in part responsible for the maintenance of life are the gluco­
corticoids, cortisol and corticosterone. Separate pathways 
from pregnenolone are required for the synthesis of these two 
steroid hormones. Multicomponent, cytochrome P-450 dependent 
hydroxylase systems are needed for the many hydroxylation steps. 
The NAD-dependent 33-hydroxysteroid dehydrogenase-Jf-3-keto 
isomerase system is responsible for the conversion of pregnen­
olone to progesterone, the initial divergent step in glucocort­
icoid biosynthesis. The responsiveness of 33-hydroxysteroid 
dehydrogenase to product inhibition and the evidence for multi­
ple forms indicate a regulatory role for 33-hydroxysteroid 
dehydrogenase. The rate of cortisol to corticosterone veiries 
from species to species. Prolonged ACTH stimulation has been 
shown to alter the ratio of glucocorticoid production in rabbits 
causing a decrease in corticosterone production and a marked 
increase in cortisol production. Increased 17̂ -̂hydroxylase 
activity with a preference for pregnenolone substrate has been 
observed to accompany these changes. Stimulation of the 17a- 
hydroxylase system may result in part from an inhibition of the 
conversion of pregnenolone to progesterone by 33-hydroxysteroid 
dehydrogenase.
CHAPTER II 
STATEME^TT OF PROBLEM
The effect of ACTH stimulation of the -3P-hydroxysteroid
dehydrogense-isomerase reaction was the subject which was inves­
tigated in this thesis. V/hether ACTH could stimulate a demon­
strable change in the specificity of microsomal 3^-hydroxyster- 
oid dehydrogenase activity or activities was the central ques­
tion.
Steroid synthesis in the adrenal gland is under the control 
of the pituitary hormone ACTH. The rabbit normally produces 
corticosterone almost exclusively but with chronic ACTH stimu­
lation cortisol levels are observed to increase while cortico­
sterone levels decrease. Increased cortisol production is accom­
panied by a rise in lycc-hydroxylase activity. l?ct-Hydroxyla- 
tion of pregnenolone has been shown to be favored over 17d- 
hydroxylation of progesterone.
The increased conversion of pregnenolone to lya-hydroxy- 
pregnenolone in ACTH-stimulated adrenal tissue could be explained 
partially by an inhibition of 3P-hydroxysteroid dehydrogenase 
which would permit more pregnenolone to be lya-hydroxylated.
Rates of (4-^^C)progesterone formation from (4-^^C)pregnenolone 
in washed microsomes from the adrenals of control and ACTH- 
treated rabbits were measured. A lower rate of (^-^^C)progeste­
rone formation might be expected in the microsomes from ACTH- 
stimulated rabbits. One shortcoming can be encountered with
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the use of radioactive substrates. The measurement of the rate 
of formation of radioactive product assumes that the specific 
activity of the product is the same as that of the added substrate. 
In other v/ords, it is assumed that the radioactive pregnenolone 
substrate added to the microsomal preparations is not diluted 
significantly by any endogenous, nonradioactive pregnenolone.
For this reason a second method of measurement of rate involving 
nonradioactive substrate and radioimmunoassay techniques were 
employed so that total progesterone formation from endogenous 
and exogenous substrate can be measured.
The effect of ACTH^stimulation on the conversion of l?a- 
hydroxypregnenolone to lya-hydroxyprogesterone was also studied 
with radioactive and nonradioactive substrates. Since this con­
version is required for cortisol production, any inhibition in 
microsomes from ACTH-stimulated rabbits might be expected to 
be less than for the pregnenolone to progesterone conversion 
or a stimulation of this activity might occur due to ACTH treat­
ment.
170 -̂Hydroxylase activity was measured in each microsomal 
preparation in order to confirm the stimulation of the adrenals 
of the ACTH-treated rabbits. Also, electron microscopic exam­
inations were made of the adrenal tissues to find further evid­
ence of stimulation.
Another objective of this thesis was to measure cytochrome 
P-450 levels in control and ACTH-stimulated microsomes. An 
increase in the cytochrome in the ACTH-stimulated tissue could 
in part explain the increase in l?a-hydroxylation.
CHAPTER III 
EXPERIMENTAL METHODS AND MATERIALS
Animals
1* Rabbits. Male New Zealand white rabbits weighing approx­
imately 1.8 to 2.7 kg were injected with either an ACTH
preparation of a vehicle. Their excised adrenals were
used for in vitro assays of 33-hydroxysteroid dehydrogenase 
and 17a-hydroxylase activities.
Chemicals
1. Radioactive Materials
a. (^-^^C)Pregnenolone, CFA.271* Batch 16, Amersham.
b. 17<i-Hydroxy(7<i-^H)pregnenolone, TRK.2$4, Batch 2, Amersham.
c. {la^2ol-^)Progesterone, TRK.34l, Batch 12, Amersham.
d. 17a-Hydroxy(7n-%)progesterone, TRK.315, Batch 9, Amersham.
e. (7^-^H)Pregnenolone, TRA.157# Batch 3* Nuclear-Chicago. 
Note: All radioactive materials were checked for purity by 
thin-layer chromatography and chromatographically purified 
as needed.
2. Cofactors and Additives
a. Diphosphopyridine nucleotide (P-NAD), Grade V, Sigma.
b. Triphosphopyridine nuceotide, reduced (NADPH), Type I.
c. Glucose-6-Phosphate, disodium salt. Grade A, Calbiochem
d. Glucose-6-Phosphate Dehydrogenase, XV, Sigma.
e. 2a - Cyano-4,4,17-trimethl andro st-5-en-17tt-l-3-one (Cyanoketone), Sterling-Winthrop Research Institute.
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3* Buffers
a. Krebs-Ringers Phosphate (KRP) buffer was prepared 
according to the method of Umbreit ($4).
b. 0.1 M Phosphate» 0,25 M sucrose buffer with and without0.001 M dithiothreitol, pH 6.8, will be referred toas sucrose-phosphate buffer.
c. 0.1 M Phosphate, 0.15^ M KOI, 0.001 M dithiothreitol, pH 6.8.
d. A 0.1 ^ gelatine phosphate buffer was prepared as in Radioimmunoassay of Steroid Hormones, a pamphlet by G. E.Abraham, M.D., (55) which is referred to as assay buffer.
4. Standard'Steroid Solutions
All steroid solutions were prepared by dissolving weighed 
quantities of Sigma brand crystalline steroids in redistilled 
absolute ethanol. Exact concentrations of ^-3-keto steroids 
were determined by their UV absorbance at 240 nm (56)
5. Solvents
a. Heptane, analytical grade.
b. Methylene chloride, spectral and analytical grade.
c. Ethanol, absolute, redistilled.
d. Chloroform, redistilled.
e. H2O, glass redistilled.
f. Benzene, redistilled.
g. Cyclohexane, spectral grade.
h. Ethyl acetate, analytical grade.
i. Formâmide, vacuum redistilled.
6. Chromâtogranhv Columns
Packard Lipidex 50OO was packed in glass columns for 
chromatography. The dimensions of the column beds were 
approximately I9.0 cm x 0.8 cm.
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?• Paper Chromât o graphv
Whatman No* 1 filter paper (46 cm x 57 cm) was eut in 2 cm 
lanes for descending paper chromatography.
8. Thin*Laver Chromatography
Quanta/Gram LQDF plates from Quantum Industries were used 
for thin-layer chromâtogrphy.
9. Scintillation Fluid
Beckman Ready-Solv E. P. was used for liquid scintillation 
spectrophotometry.
10. Gases
Nitrogen and carbon monoxide were supplied by Industrial 
Air Products, Inc.
11. ACTH
a. Clinical grade ACTH, #7940-JO-85, approx. 33 I.U./mg 
was a gift from Samuel Epstein, Hormone Research Lab.
b. Natural porcin MOD IV, Lot:K?000 52 C, potency S.C.
77 U/mg, I.V. 120 U/mg, 4-15-77, was a gift from R. J. 
Schurte, Armor Laboratories.
12. Antibodies
Progesterone antibody, S-?#4, and 17c-hydroxyprogesterone 
antibody, S-4$#6, were purchased from G. E. Abraham, M.D. 
of General Harbor Hospital, the Division of Reproductive 
Biology, Torrance, California.
13* Reagents
a. 2% Na K Tartrate in glass redistilled H^O.
b. 2^ Na^CO^ in 0.1 N NaOH.
c. Ifo CuSOjî -SĤ O in glass redistilled H2O.
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d. Phenol Reagent (Folin-Ciocalteu Reagent) diluted to 1 N, Anderson Lab, Inc.
14. Miscellaneous Chemicals
a. Bovine serum albumin, Graction V, B grade, Calbiochem.
b. Sodium Hydro sulfite, Kallinckrodt.
c. Dithiothreitol, Sigma.
d. Korit A Charcoal, Scientific Supplies, Co.
e. Dextran T-?0, Pharmacia, Co.
f. Glutaraldehyde, 25^ aqueous solution, Aldrich.
g. Peanut oil, 100^ pure.
h. Beeswax, Stampac, Corp.
i. Phenol, analytical grade, Mallinckrodt.
ACTH Preparations 
A 5% beeswax in peanut oil solution was sterilized at 
260^C for 30 minutes. Enought crystalline phenol was dissolved 
in the peanut oil-beeswax solution to make a 0.5% solution.
A weighed amount of powdered ACTH was added to the vehicle to 
make a 25 I.U./0.2 ml suspension. The ACTH was dispersed with 
use of a Branson sonifier on a setting of 4. The suspension 
was sonified in short bursts in order to avoid excessive heating 
of the suspension. The suspension was transferred by sterile 
technique into sterile serum bottles. The bottles were sealed 
with sterile serum stoppers. The ACTH suspension and a 5% 
beeswax in peanut oil vehicle without ACTH were stored at 4°C.
Microsome Preparation 
The rabbits were weighed on day 1 of the ACTH injection 
period prior to the first injection. The experimental rabbits
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were injected int ramus cul arily with 0.2 ml of the ACTH in the 
55̂  beeswax-peanut oil vehicle two times daily for three days.
The control animals were injected similarily with beeswax- 
peanut oil vehicle only. On day 4 the animals were weired 
again and were sacrificed. Their adrenals were excised and 
each gland was weighed after being trimmed of fat and connect­
ive tissue. After weighing, the -adrenals v/ere kept between 
gauze soaked in O.95S saline. The tubes were kept in an ice 
bath. After all the adrenal had been excised, each group of 
adrenals was minced over ice and was rinsed with a phosphate 
buffer containing 0.154 H KCl, pH 6.8, to remove adsorbed hemo­
globin. The tissue was homogenized in 9 ml sucrose-phosphate 
buffer containing DTT, pH 6.8, per gram of tissue with a min­
imal number of passes of a ground-glass pestle attached to a 
variable speed motor.
The homogenate v/as centrifuged on a Sorvall refrigerated 
centrifuge Model RC2-B using a SS-34 rotor at 99O rpm (90OO 
X g) for 20 minutes at 4^0. The supernatant was removed with 
a cold syringe and the pellet containing nuclei, cell debris 
and mitochondria v/as discarded. A second centrifugation of 
the supernatant was done at 11,500 rpm (12,000x g) for 10 minutes 
to remove lighter mitochondria. The supernatant was centri­
fuged on a Beckman ultracentrifuge Model L2-65B using a Type 
65 rotor at 42,000 rpm (105,000 x g) for 60 minutes. The result­
ing pellet was designated the microsomal fraction (16).
The pellet v/as resuspended and centrifuged twice more at
42,000 rpm for 60 minutes in a phosphate buffer containing
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KCl and DTT, pH 6.8, to remove adhering protein. The final 
pellet was resuspended in sucrose-phosphate buffer, pH 7.0, 
to a concentration of 2 ml per adrenal. Figure 8 is a flow 
diagram of the above centrifugation prodedure.
33-HydroXV Steroid Dehydrogenase Assay 
3p-Hydroxysteroid dehydrogenase activity in the control 
and ACTH-stimulated microsomal preparations was measured as the 
rate of product formation from two substrates, pregnenolone 
and 170L-hydroxypregnenolone. The product which was formed from 
radioactively-labelled substrate was measured by liquid scin­
tillation spectrophotometry after chromatographic separations. 
Product formed from nonradioactive substrate was measured by 
radioimmunoassay which measured both product formed from exo­
genous substrate and product formed from endogenous substrate, 
if any were present.
Radioactive substrates were (4-^^C)pregnenolone and l?a- 
hydroxyC?tt-^H)pregnenolone whose specific activities were adjus­
ted to either 0.5 /*ci per 20 or 50 nmol with nonradio active 
steroid. Each substrate amount was contained in a volume of 
0.2 ml propylene glycol-ethanol (1:1 v/v). Each 0.2 ml volume 
was pipetted into a 25 ml Erlenmeyer flask. The ethanol was 
evaporated under nitrogen in a 40°C water bath.
The microsomal preparations were diluted 1:8 with the 
sucrose-phosphate buffer, pH ?.0, and were placed in 25 ml 
flasks. The microsomes were gassed with carbon nomoxide for 
two minutes to inhibit hydroxylase activity. The flasks were 
sealed with serum stoppers and were placed in a 37*5^0 shaking
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10% ADRENAL TISSUE HOMOGENATE (w/v) 0.25 M sucrose-0.1 M phosphate-0.001 M DTT _____________buffer. oH 6.8 __________
PELLET(Nuclei, Cell Debris)
£PELLET(Mitochondria)
IPELLET(Mitochondria, some Microsome)
SUPERNATANT (Soluble Fraction)
9000 X  g, 20 min.
SUPERNATANT
12,000 X  g, 10 min.
SUPERNATANT
17,500 X g, 30 min.
SUPERNATANT
105,000 X g, 60 min.
MICROSOIvIAL PELLET0.154 M KGl-0.1 M phosohate-0.001 M DTT buffer, pH 6.8
105,000 X g, 60 min. (twice)
"washed"
MICROSOMAL PELLET
resuspended in 0.25 M sucrose-0.1 M phosphate buffer, pH ?.0, 2 ml/adrenal
Figure 8. Microsomal preparation flow sheet.
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water bath. Prior to incubation 0.85 ml of KRP buffer, pH 
7.0, and 50 /a1 of 20 mM NAD, equaling 0.001 nmol NAD, were 
added to each flask containing substrate. Each flask was gassed 
with carbon monoxide for a half minute and prewarmed to 37*5^C 
before incubation. One milliliter of microsomal suspension 
was added to the flasks to start the reaction. Reaction times 
were 0, 10, 20 and 40 seconds. The reaction was terminated 
by addition of 5 ml of cold CH2CI2» thorough mixing and immed­
iately placing in a minus 10°C freezer. The CH2CI2 was added 
to the zero time flasks prior to the addition of microsomes. 
Flasks containing substrate, cofactors and buffers but no tis­
sue were incubated at 40 second intervals and were referred 
to as blanks.
Analysis of the reaction products began with CH2CI2 extrac­
tion. Three milliliters of glass redistilled water were added 
to each thawed flask. Prior to the extraction a recovery tra­
cer of (la-,2a-,progesterone or 17ct-hydroxy(7n-^H)progest­
erone of approximately 2000 dpm was added to each flask cont­
aining nonradioactive substrate. The contents of the flasks 
were emptied through funnels into extraction tubes and 5 ml 
of CH2CI2 was used to rinse each flask. The funnels were rinsed 
with 5 ml of CH2CI2 into the extraction tubes. The extraction 
tubes were mixed on a Vortex mixer for two minutes and then 
were centrifuged at approximately 1800 rpm for 10 minutes.
The lower CH2CI2 phase was trasferred into a receiving tube with 
a serum lifter. The serum lifter was rinsed with 5 ml of CH2CI2 
into the extraction tube. The procedure was repeated and the
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combined extraction volumes were dried under nitrogen. The 
tubes were rinsed three times with 10, 5» and 3 drops absolute 
ethanol to concentrate extracted material on the bottom of 
the tube.
Prior to being chromatographed on the Lipidex 5000 col­
umns, each sample was redissolved in 100>ul elution solvent 
(heptaneÎCH2CI2 95:5 for the pregnenolone/progesterone separa­
tion and heptane:CH2CI2 bO:20 for the l?a-hydroxypregnenolone/
17 a -hydro xypr o ge s t er one separation). Fifty microliters of 
each radioactive sample were placed in separate counting vials 
and the remaining 50^1 were placed on the column. The column 
was opened and the volume was allowed to settle into the column 
bed. The column was rinsed twice with 100 >ul column solvent.
The column was then closed and the buret was filled to the 
zero mark. The following fractions were collected on the hep­
tane :CH2Cl2 95:5 column: fraction 1, 0-5 ml; fraction 2, 5-15
ml; fraction 3» 15-20 ml; fraction 4, 20-35 ml; and fraction 
5f 35-55 ml. Progesterone was eluted in fraction 2 and preg­
nenolone v/as eluted in fraction 4.
On the heptane:CH2CI2 80:20 Lipidex columns the following 
fractions were collected: fraction 1, 0-10 ml; fraction 2,
approx. 10-20 ml; fraction 3, approx. 20-30 ml; fraction 4, 
approx. 30-50 ml; and fraction 5» approx. 50-55 ml. l?a-Hydro- 
xyprogesterone eluted in fraction 2 while 17°̂ -hydroxypregneno- 
lone eluted in fraction 4.
The fractions which had been collected in counting vials 
were dried under nitrogen and 10 ml Beckman Ready-Solv was added
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to each vial. The vials were counted for 4 minutes on the 
Nuclear-Chicago Scintillation counter. Total dpm of the pro­
duct formed was calculated by the following formula:
r X cpm
dpm = ---------------------------recovery factor x efficiencywith
cpm 50>^1 sample ^ cpm 50not placed on column eluted from column
r = ---------------------------------------------cpm 50 >**1 eluted from column
Percent of substrate in each fraction eluted from the column 
was calculated by dividing the dpm of a fraction by the total 
dpm in substrate added to each flask. The number of nmol in 
each fraction was calculated from these percent values by mult­
iplying by the nmol of substrate used.
The nonradioactive samples were dissolved in 100>ul column 
solvent and the entire volume was applied to the column. Only 
the fraction in which progesterone or l?a-hydroxyprogesterone 
eluted was collected. The fraction was dried under nitrogen and 
was redissolved in 1 ml absolute redistilled ethanol. A 0.5 
ml aliquot was pipetted into a counting vial for a recovery 
determination. Dilutions of the sample for radioimmunoassay 
were made on the basis of the nmol calculated from the assays 
in which radioactive substrates were used to give 100-1000 pg. 
One tenth milli-volûmes of each volume were placed in duplicate 
assay tubes and were dried under nitrogen.
The radioimmunoassay procedure was modified from the method 
of Garza and coworkers (57) • The assay volume was 0.9 ml. 
Standards in the range of 25-5000 pg were assayed with each
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set of samples. One tenth milliliter of %-steroid, represent­
ing approximately 20,000 dpm and 50 pg in assay Puffer was 
pipetted into sample and standard assay tubes. One tenth 
milliliter of antibody in assay buffer was added and the tube 
contents were mixed. The assay tubes were incubated for a 
minumum of 2 hours at 4°C. Two tenths milliliter of a charcoal 
suspension in assay buffer was added to each tube and was allowed 
to stand at for 20 minutes to remove free steroid. The 
tubes were centrifuged for 10 minutes at 1800 rpm. The super­
natant was transferred to counting vials by quick inversion.
Ten milliliters Beckman Ready-Solv counting fluid was added 
to each vial and the samples were counted for 4- minutes on a 
Nuclear-Chicago scintillation counter. Percent of ^-steroid 
bound to the antibody was calculated by dividing the net cpm 
of the sample by the total net cpm of the steroid. A zero stan­
dard containing only antibody and ^-steroid was used to cal­
culate a Bq value, that is the ratio of ^H-steroid bound to the 
antibody in the absence of nonradioactive steroid. A standard 
curve was made by plotting the pg of unlabelled steroid on a 
log scale versus the logit of B/B^ x  100 (58).
17oc-Hvdroxvlase Assay 
(4--̂ ^C)Pregnenolone with a specific activity of 0.2/tci 
per 25 nanomoles per 0.2 milliliter propylene-glycol ethanol 
(1:1 v/v) was used as a substrate for this assay. Two hundred 
microliters of the substrate and 50 >ul of 10 M cyanoketone, 
a 33-hydroxysteroid dehydrogenase inhibitor (59)t in propylene 
glycol-ethanol (1:1 v/v) were pipetted into each incubation
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flask. One milliliter of microsomal suspension sucrose-phos­
phate buffer was added to each flask to start the reaction.
The flasks were incubated at 37»5 ± 0.1 and the reaction 
was terminated after 2 minutes with addition of 5 ml cold CH^Cl^, 
immediate mixing and placing in a -10 freezer. Again, the 
CH2CI2 was already in the zero time flasks when the microsomes 
were added.
Five hundredths of a micro curie of both (?a-^) pregnenolone 
and 17tt-hydroxy(7n-^H)pregnenolone were added to the flasks 
before extraction as recovery standards. The extraction pro­
cedure was the same one used for the 3^-hydroxysteroid dehydro­
genase assay. After drying under nitrogen the extract was 
redissolved in 1 ml absolute redistilled ethanol. Two 50/*1 
aliquots were taken for recovery determinations.
The remainder of the samples were analyzed by combination 
of paper and thin-layer chromatography. Fifty micro grams of 
progesterone and fifty micro grams of 17<^-hydroxyprogesterone 
were added to each extract. Whatman no. 1 paper strips with 
dimensions of 45 cm x 2 cm were saturated with formamide: metha­
nol (1:1 v/v) (60). Excess solvent was blotted between sheets 
of Vftiatman no. 1 filter paper. The extracts were redissolved 
in three drops CHCl^:methanol (1:1 v/v) and applied to the paper 
strips in a thin horizontal line. The strips were developed 
by descending chromatography first in a heptane : formamide sys­
tem. The strips were allowed to develop in this system one 
hour after a drop of the mobile phase had formed on the end of 
the paper strip (60). Then the strips were developed to the 
end of the paper in a benzene:formamide system. After drying
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overnight the progesterone and ly^-hydroxyprogesterone areas 
were visualized and marked under ultraviolet light. The strips 
were scanned hy a Packard radiochromategram scanner. The strips 
were lined up with the peaks on the radio chromatogram tracings 
and each area corresponding to a peak was cut out and eluted 
with 15 ml absolute ethanol. The eluates were dried and redis­
solved in 1 ml absolute ethanol. A second recovery aliquot 
of 50 ><1 was taken in duplicate.
The eluted area corresponding to lya-hydroxypregnenolone 
was redissolved in 50 >h1 CHCl^ and 25/^1 was applied to a lane 
of a Quanta LQDF TLG plate. Five micrograms of l?a-hydroxy- 
progesterone, l?a-hydro xypregneno lone, 21-hydro xypregneno lone, 
113-hydroxyprogesterone and 11-deoxycorticosterone were applied 
to alternate lanes of the plate. Five micrograms of l?a-hydroxy- 
progesterone, llP-hydroxyprogesterone and 11-deoxycorticosterone 
were developed in the sample lanes. The plates were developed 
in cyclohexane: ethyl acetate 85:115 for one hour. The plates 
were allowed to dry and were redeveloped in the same system for
h,another hour, a -3-Ketosteroids in the alternate lanes were 
visualized and marked under ultraviolet light. a^-3P"Hydroxy- 
steroids were visualized by spraying hot H2S0ĵ: ethanol 1:1 
solution which resulted in a color reaction at their location 
(61).
The plates were scanned using the Packard radio chromato­
gram scanner and the areas corresponding to l?a-hydroxypreg- 
nenolone were scraped into counting vials. Ten milliliters of 
Beckman Ready-Solv were added to each vial and the samples were
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counted for 4 minutes each on the Nuclear-Chicago scintillation 
counter- The total dpm of 1?^-hydroxy(4-^^C)pregnenolone were 
calculated by the following formula:
2 X cpm
dpm = recovery x efficiency
The nmol of 17a-hydroxy(4-^^C)pregnenolone formed was calculated 
from the percent of total dpm added as substrate. The rate of 
l?a-hydroxy(4-^^C)pregnenolone formation was expressed as nmol 
of 170:-hydroxy(4-^^C)pregnenolone per minute per mg protein-
Cytochrome P-4S0 Determination 
Part of each microsomal preparation was set aside for a 
spectrophotometric cytochrome P-450 determination. The proce­
dure used v/as that of Omura and Sato (62). Content of cyto­
chrome F-450 v/as expressed as nmol per mg protein.
Protein Determination 
Protein content of the microsomal preparations was deter­
mined with bovine serum albumin standards by method of Lowry 
et ai- (63).
Electron Microscopic Examinations 
Small pieces of adrenal tissue approximately 1 mm square 
were cut from glands used in the microsomal preparations. Both 
control and ACTH-treated adrenal tissue were used. The tissue 
was placed in a 10% solution of glut ar aldehyde and was given to 
E. M. Technicians Virginia Carrano and Dan Long for thin-sect- 
ioning and scanning.
CHARPTBR IV 
RESULTS
3P-Hydroxysteroid Dehydrogenase Assay; Pregnenolone as the Substrate
Microsomes prepared from control and ACTH-stimulated rab­
bits adrenals were incubated with both pregnenolone and
nonradioactibe pregnenolone substrates. Average paired adrenal 
weights for the control and ACTH-stimulated rabbits were I23.O 
mg (range 116.2-130.4, n=6) and 158.0 mg (range 132.2-197.4 
mg, n=6) respectively. The protein content of the control 
microsomal suspension per incubation flask was 0.037 mg while 
the protein content of the ACTH-stimulated microsomal suspen­
sion per incubation flask was O.058 mg.
Results of the assay using (4-^^C)pregnenolone as a sub­
strate are shown in Table 1. The incubation time in seconds 
is plotted against nmol of (4-^^C)progesterone formed from the 
substrate per mg of protein in Figures 9-12. In general, the 
rate of (4-^^C) progesterone formation was linear over the 40 
seconds incubation time. Rates of formation of (4-^^C)proges­
terone in control microsomes were calculated to be 17.4 t 3.6 
nmol per minute per mg protein at 20 nmol substrate (Î values 
are standard deviations) and 23.4 ± 3.6 nmol per minute per mg 
protein at 50 nmol substrate. The rates for microsomes from 
ACTH-stimulated rabbits were 22.8 ± 8.4 and I9.8 i 6.6 nmol
per minute per mg at 20 and 50 nmol substrate respectively. 
l4C-Labelled pregnenolone concentrations of 20 and 50 nmoles
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Table 1
33-Hydroxysteroid dehydrogenase assay of microsomal preparations 
using pregnenolone as a substrate.
Tissue
Substrate
Concentration
nmol 
0 sec
(4- 0)progesterone formed 
per mg protein 
10 sec 20 sec 40 sec
Rate curve 
correlation 
coefficient
values 
slope f 8.D.
Control 15.1 1(9.4-20.7)-̂ 19.1
19.6 27.2 0.98 0.29
ZO nmol (15.9-22.3) (16.9-22.0) (23.4-30.6) ♦ 0.06
Control 
50 nmol
16.4
(14.0-18.5)
2discarded 25.8 32.0
(single pt.)(37.4-36.6) 0.99 0.39i 0.06
ACTH 4.8 15.3 t 16.2 21.9 0.92 0.38
20 nmol (2.6-6.9) (12.6-18.1) (single pt.)(single pt.) + 0.14
ACTH 10.2 14.7 20.9 23.4 0.95 0.3350 nmol (8.6-11.6) (12.2-17.1) (13.4-28.1) (single pt.) i 0.11
^Numbers in parentheses are the range of duplicate values. 
Values discarded because of technical error.
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Figure 11. 3P-HYDROXYSTEROID DEHYDROGENASE ASSAY
Values from Table 1,Tissue: ACTH-stimulatedSubstrate: (4-14c)pregnenolone
Substrate amount: 20 nmol
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Substrate amount: 50 nmol
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had been found previously to be saturating for the enzyme (64). 
Therefore, both control and ACTH-stimulate tissues appear to 
have a maximal rate of about 23 nmol per minute per mg protein.
The formation of progesterone from nonradioactive preg­
nenolone was measured by radioimmunoassay techniques. Figure 
13 is a typical standard curve of the progesterone radioimmuno­
assay. The standard curve was found to be reproducible from 
one assay to the next. The best accuracy of the curve was 
found to be between 100 to 1000 pg of progesterone.
The results of the 3^-hydroxysteroid dehydrogenase assay 
using nonradioactive pregnenolone as a substrate are shown in 
Table 2. Formation rates of progesterone for control micro- 
somes were 17-6 nmol per minute per mg protein at 20 nmol of 
substrate and 22.1 nmol per minute per mg protein at 50 nmol 
of substrate. Formation rates of progesterone for microsomes 
from ACTH-stimulated rabbits were 39*3 and 12.3 nmol per minute 
per mg protein at 20 and 50 nmol of substrate respectively.
A comparison of rates obtained by radioactive methods and rad­
ioimmunoassay methods are shown in Table 3«
A l?a-hydroxylase assay was done on the microsomal prepa­
rations mentioned above, but because of technical error no 
valid data could be obtained.
3P-Hvdroxvsteroid Dehydrogenase Assay; 17a-Hydroxynregnenolone as the Substrate
3^-Hydorxysteroid dehydrogenase assays using 17cc-hydroxy­
's( H-7n) pregnenolone and nonradioactive 17<i-hydroxypregnenolone 
as substrates were done on microsomes from control and ACTH- 
treated rabbits. Two separate assays were performed on micro-
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Figure I3.. Typical standard curve of progesterone radioimmunoassay.
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Table 2
3P-Hydroxysteroid dehydrogenase assay using 
nonradioactive pregnenolone as a substrate.
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TissueSubstrateConcentration
nmol progesterone formed per mg protein 0 sec 4o sec
Control 5.4 , 17.120 nmol (4.6-6.2)-^ (11.6-21.0)
Control 8.7 23.450 nmol (7.0-10.2) (single pt.)
ACTH 1.9 28.120 nmol (1.6-2.1) (22.8-33.6)
ACTH 5.9 14.150 nmol (5.6-6.2) (12.8-15.5)
l.TNumbers in parentheses are the range of duplicate.
Table 3
33-Hydroxysteroid dehydrogenase rates from 
assays using pregnenolone and nonradio-
active pregnenolone as substrates.
TissueSubstrateConcentration
Rat es-nmol per min per mg protein radioactive method RIA method+ S.D. (range)
Control 17.4 17.620 nmol i 3.6 (16.5-18.6)
Control 23.4 22.050 nmol t 3.6 (single pt.)
ACTH 22.8 39.020 nmol t 8.4 (38.1-40.5)
ACTH 19.8 12.350 nmol + 6.6 (10.3-14.4)
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somes from two separate control groups of rabbits and from 
three separate groups of ACTH-stimulated rabbits. Experiment 
I designates the assays done using microsomal preparations from 
control rabbits and rabbits which had been injected with the 
Epstein-ACTH preparation (see Method and Material). Average 
paired adrenal weights from Experiment I for the control and 
ACTH-stimulated rabbits were 151*5 mg (range 97*3-198.0, n=9) 
and 156.1 mg (range 104.7-212.? mg, n=8), respectively. The 
protein content of the control microsomal suspension per incub­
ation flask was 0.034 mg, while the protein content of the 
ACTH-stimulated microsomal suspension per incubation was 0.053 
mg.
Results of Experiment I using l?a-hydroxy(7n-^H) pregnen­
olone as substrate showed zero time values. Collection of two 
40 seconds incubation extracts on a fraction collector revealed 
two unidentified peaks in Fraction 1 which precedes the l?a- 
hydroxyprogesterone elution volume. Eventually, it was discov­
ered that the plastic tips of the Lipidex chromatography columns 
had been retaining radioactivity and were the source of contam­
ination. The tips were replaced.
While no reliable data could be obtained from the 3P“ 
hydroxysteroid dehydrogenase assays with radioactive substrate, 
radioimmunoassay of the incubation extracts did yield values 
for the rate of fondation of 17<^-hydroxyprogesterone from 17ct- 
hydroxypregnenolone. Figure 14 is a typical standard curve for 
the 17ct-hydroxyprogesterone radioimmunoassay. The accurate 
range of the curve was found to be between 100-1000 pg. The
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Table 4
3^"Hydroxysteroid dehydrogenase assay of microsomal preparations using non­radioactive 17ÔC-hydroxypregnenolone as a substrate.
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TissueSubstrateConcentration
nmol per mg protein 
0 sec 40 sec
Rate nmol/min/ mg protein
Control 33.0 68.4 53.120 nmol (45.0-61.1)
Control 37.4 95.8 87.650 nmol (72.8-102.4)
ACTH 41.2 72.9 47.620 nmol (24.8-70.5)
ACTH 53.2 113.3 90.150 nmol (single pt.)
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results of the 3P-hydroxysteroid dehydrogenase assay with non­
radioactive 170c-hydroxypregnenolone substrate are given in 
Table 4,
The substrate concentrations which appeared saturating 
in the pregnenolone substrate experiments were apparently not 
saturating in the present 17tt-hydroxypregnenolone substrate 
experiments • Apparent and Kĵ  values for control micro­
somes were calculated to be 161 nmol per minute per mg protein 
and 2.10 x 10“^ M respectively. Apparent and values
for the microsomes from ACTH-stimulated rabbits were 222 nmol 
per minute per mg protein and 2.31 x lO"^ M respectively.
A 170L-hydroxylase assay was done on the Experiment I micro­
somal preparations. Preliminary separation of products of the 
17tt-hydroxylase extracts was accomplished by paper chromato­
graphy. Two major peaks corresponding to (4-^^C) pregnenolone 
and 17<i-hydroxy(4-^^C)pregnenolone were present in all of the 
radiochromatograms however# other unidentified peaks were in 
a number of separations. Small peaks at the origin probably 
represent irreversibly adsorbed radioactive material which 
failed to migrate. Multiple peaks were observed in the area 
between (4-^^C) pregnenolone and 17cx-hydroxy(4-^^C) pregnenolone 
on some of the paper radio chromatogram scans. The appearance 
of these unidentified products was not tissue-dependent since 
they were also found in extracts from incubations in which sub­
strate, cofactors and buffer but no tissue were present. Figure 
15 is a radio chromatogram tracing of the extract from a control 
2 minute 170^-hydroxylase assay. One unidentified peak is seen 
at the origin. Figure 16 is a similar tracing of the extract
100
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Figure 15. Radiochromatogram tracing of control 2 minute -hydroxylase assay. (A) represents progesterone while (B) represents 17a-hydroxypro- 
gesterone which were visualized under ultraviolet light. Hashed 
area represents area corresponding to 17a-hydroxy(^-i^C)pregnen­
olone which was eluted with ethanol and chromatographed on a thin- 
layer chromatography system.
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Figure 16. Radiochromatogram tracing of ACTH 2 minute 17ct-hydroxylase assay, 
(A) represents progesterone while (B) represents 17(i-hydroxypro- gesterone which were visualized under ultraviolet light. Hashed 
area represents area corresponding to 17̂ -̂hydroxy(̂ -l4c)pregnen­
olone which was eluted with ethanol and chromatographed on a thin- 
layer chromatography system.
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from an ACTH 2 minute 1?^-hydroxylase assay, A large unident­
ified area of closely set peaks is seen in the area in which 
l?(ï-hydroxyprogesterone migrates.
Thin-layer chromatography of the 17cL-hydroxy(^-^^G)pregn­
enolone area from the paper chromatographic separations showed 
fairly sharp peaks in the area where l?a-hydroxypregnenolone 
migrates. Small peaks closer to the origin than the 17^-hydroxy- 
pregnenolone were observed in some of the thin-layer 
chromatograms. No product identification of the unkown peaks 
was attempted. Figure 17 is a scan of the radioactivity on a 
thin-layer chromatogram of the 17(^-hydroxypregnenolone area 
from the paper chromatogram seen in Figure 15- A small peak 
which migrates behind 11-deoxycorticosterone is present. Figure 
18 is a thin-layer radio chromatogram scan of the 170L-hydroxy- 
pregnenolone area recovered from the paper chromâtogram repre­
sented in Figure 16. A few very small unidentified peaks were 
seen in this radio chromatogram also. The major peak in all of 
the thin-layer chromatograms of the 170^-hydroxypregnenolone area 
from the paper chromatographic separations was the 17a-hydroxy- 
pregnenolone peak.
Results of the 17(i-hydroxylase assay of the Experiment I 
microsomal preparations based on the formation of 17ct-hydroxy- 
(4-^^C ) pregnenolone from (4-^^C) pregnenolone are shown in Table 
5* The rate of formation of 170^-hydroxy(4-^^C)pregnenolone in 
the microsomes from ACTH-stimulated rabbits was three times 
higher than the rate obtained for the control microsomes. This 
rate is considerably lower than those obtained in previous exp­
eriments (64) which would indicate little stimulation of adrenal
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Distance from Origin, cm
Thin-layer radiochromatogram scan of l?a- hydroxjrpregnenolone area from paper chrom­atogram seen in Figure 14. (A), (B) and (E)
represent 11-deoxycorticosterone, 110-hydroxy- 
progesterone and l?a-hydroxyprogesterone which were visulaized under ultraviolet light. (C) and (D) are 21-hydroxypregnenolone and 17a- 
hydroxypregnenolone which were visualized with 
a color reaction.
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Figure 18 . Thin-layer radiochromatogram scan of 17o^ hydroxypregnenolone area from the paper chrom­
atogram seen in Figure 15. (A), (B) and (E)represent 11-deoxycorticosterone, 13/3-hydroxy progesterone and 17oi^hydroxy^rogesterone which 
were visulalized under ultraviolet light. (C) 
and (D) are 21-hydroxypregnenàlone and 17o<r 
hydroxypregnenàlone which were visualized with 
a- H2SO4 color reaction.
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Table 5
17a-Hydroxylase assay of Experiment I 
microsomal preparations.
TissueTime Proteinmg fo Conversion nmol per min of Substrate per mg protein
Control 0 Time 0.273 0.10
_2
ACTH^0 Time 0.430 0.15
-
Control 2 min 0.273 0.35 0.11
ACTH 2 min 0.430
1.24 0.32
Blank 2 min 0
0.15 —
ACTH-5/*̂  beeswax in peanut oil suspension used the clinical grade, #79^0-JO-58? approx. 33 I.U./ mg of Samuel Epstein, Hormone Research Laboratory.
Zero time values subtracted.
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tissue by ACTH.
Experiment II employed a microsomal preparation from con­
trol rabbits and two microsomal preparations from rabbits which 
were injected with two different ACTH preparations. One group 
of rabbits was injected with the Epstein-ACTH suspension which 
had been used in Experiment I. Another group was injected with 
a highly purified preparation, that is, the Armor-ACTH prepara­
tion of R.J.Schlurte of Armor Laboratories (see Method and Mat­
erials section)•
Average paired adrenal weights for the control rabbits 
was 122.0 mg (90,3 to 18?.0 mg, n=8). Average paired adrenal 
weight for rabbits receiving the Armor preparation was 135*5 mg 
(102.1-163.4, n=8). The rabbits injected with the Epstein-ACTH 
had an average paired adrenal weight of II9.0 mg (91.7-171*8, 
n=6). The protein content of the control microsomal preparation . 
per incubation flask was 0.026 mg. The protein content of the 
Armor-ACTH microsomes per incubation flask was 0.035 mg. The 
microsomal preparation from the Epstein-ACTH treated rabbits 
was not used for 3P“bydroxysteroid dehydrogenase assay but only 
for a 17ot-hydroxylase assay to determine the degree of stimulation.
The results of the 3P-hydroxysteroid dehydrogenase assays 
of Experiment II using 50 nmol 1 7 -hydroxy(?n-%) pregneno 1 one 
as substrate are given in Table 6. The incubation time in sec­
onds is plotted against the nmol of 17oc-hydroxy(7n-^)progest­
erone formed per mg protein in Figures 19 and 20. Reliable 
values could be obtained only for the 50 nmol substrate levels 
because of column contamination present with chromatographic 
separations of the extracts of the 20 nmol incubations. The
Table 6
3P-Hydroxysteroid dehydrogense assay of microsomal preparations 
using 17ot-hydroxy(7n-^H)progesterone as a substrate.
Tissue
Substrate
Concentration
nmol 17tt-hydroxy(7n-^H)progesterone 
formed per mg protein 
0 sec 10 sec 20 sec 40 sec
Rate curve values 
correlation slope 
coefficient + S.D.
Control . ^7.3 . 65.5 , 71.5 96.7 0.99 1.2250 nmol (î3.3-51.1) ($6.8-74.3) (53.5-89.5) (85.3-108.1) t 7.2
ACTH 1̂7.3 , 61.7 66.0 83.0 0.99 0.8550 nmol (21.2-73.2) (49.5-73.B) (55.6-76.3) (80.1-85.9) ♦ 8.4
‘Numbers in parentheses are the range of duplicate values.
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rate of l?ci-hydroxy(7n“^H) pregnenolone formation in control 
microsomes was 73.2 + 7.2 nmol per minute per mg protein at 
50 nmol substrate. The rate of product formation with microsomes 
from Armor-ACTH stimulated rabbits was $1.0 + 8.4 nmol per min­
ute per mg protein.
The results of the 33-hydroxypregnenolone dehydrogenase 
assay using nonradioactive 17ct-hydroxypregnenolone are shown 
in Table 7 with a comparison of values obtained by the radio­
active method. Control rates were measured to be 4$.l and 76.1 
nmol per minute per mg protein at 20 and $0 nmol substrate, 
respectively. ACTH-stimulated microsomal rates were 46.4 and 
53*3 nmol per minute per mg protein for 20 and $0 nmol substr­
ate, respectively. Apparent and values for control
microsomes were 188 nmol per minute per mg protein and 2.59 x 
10”^ K, respectively. Apparent and values for ACTH-
stimulated microsomes were 58.8 nmol per minute per mg protein 
and 0.27 X 10 respectively.
Because peoduct inhibition was suspected to occur in the 
3P-hydroxysteroid dehydrogenase assays a 1:1 (v/v) KRP buffer: 
serum was added to some of the incubation flasks with microsomes 
from control and ACTH-treated rabbits. The steroid-binding prop- 
erites of some serum components would prevent product from inhi­
biting 3P-hydroxysteroid dehydrogenase activity (65*66). The 
amount of substrate used in these incubations was 50 nmol. The 
results are listed in Table 8 which includes a comparison of 
values obtained without serum addition from Table 7- The rates 
obtained from the assays with serum:buffer are higher than those 
obtained with buffer only.
Table 7
3P-Hydroxysteroid dehydrogenase assay of microsomal preparations using 17a-hydroxy- 
(7n-3H)pregnenolone and nonradioactive 1 7 -hydroxypregneno1one as substrates.
Tissue Radioactive Method Radioimmunoassay MethodSubstrate 0 sec 40 sec Rate 0 sec 40 sec Rate
Concentration (nmol/^mg. protein)*(nmol/min/mg) (nmol/mg protein) (nmol/min/mg)
Control 20 nmol
_1 - 15.6 48.3 49.1(single pt.)
Control 
50 nmol 47.3 96.7
73.2 
i 3.5
39.0 «9.7 76.1 (single pt. )
ACTH 
20 nmol
- - - 16.7 47.6 46.4 
(single pt.)
ACTH 
50 nmol 47.3
83.0 51.0 
t 8.2 23.6 59.1 , 53.5(43.2-63.3)
^Values obtained 
not used because
for these tissues and 
of technical errors.
substrate iconcentrations were
a
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Table 8
3P-Hydroxysteroid dehydrogenase rates from 
assays using 17 -hydro xy ( ?n- ) pr e gneno lone and nonradioactive l?ct-hydroxypregnenolone as substrates- Comparison of incubations with 
buffer only and with serum:buffer solution.
Tissue Rates-nmol/min/mg proteinSubstrate Radioactive RIAConcentration Method Method
Control 73-2 76.150 nmol
Control 106-9 84.050 nmol
with serum
ACTH 51.0 53.550 nmol
ACTH 70.5 86.950 nmol
with serum
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Table 9
1 7 -Hydroxylase assay of Experiment II microsomal preparations.
TissueTime proteinmg fo Conversion of Substrate nmol/min/ mg protein
Control 0 Time 0.209 0.03
_1
ACTH^0 Time 0.281 0.21
-
ACTH^0 Time
0.110 0.12 -
Control 2 min 0.209 0.49 0.11
ACTH^ 2 min 0.281 2.67 1.11
ACTH^ 2 min
0.110 1.11 1.12
Blank 0 0.14 -
^Zero time values subtracted.
ACTH-5^ beeswax in peanut oil suspension used was the clinical grade, #79040-J0-85» approx. 33 I.U./ mg from Samuel Epstein, Hormone Research Laboratory.
^ACTH-5^ beeswax in peanut oil suspension used was the natural porcine, MOD IV, Lot:K7000 52 C, potency 
S.C. 77 U/mg, I.V. 120 U/mg, 4-15-77 of R.J. Schlueter, Armour Laboratory.
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The 17^-hydroxylase assays of the microsomal preparations 
from Experiment II are shown in Table 9* The rate of l?a-hydroxy- 
(4-^^C)pregnenolone formation in control tissue equaled the 
value obtained in the Experiment I 17tt-hydroxylase assay. Both 
tissues from ACTH-stimulated rabbits had significantly higher 
rates than the control tissue and the tissue from ACTH-treated 
rabbits in Experiment I. These results indicate successful 
stimulation of adrenal tissue by both ACTH preparations.
Cytochrome P-4$0 determinations were done on each micro­
somal preparation desorbed above. Figure 21 is a typical car­
bon monoxide difference spectrum used to measure the amount 
of cytochrome in the microsomal suspension. Table 10 gives the 
results of the cytochrome P-450 determinations. In general, 
the ACTH microsomes contained slightly less nmol cytochrome per 
mg protein than did the control microsomes. However, the cyto­
chrome determinations of Experiment II showed greater values for 
microsomes from ACTH-treated rabbit adrenals.
Electron microscopic examinations of the adrenal tissue 
from the Experiment I and Experiment II rabbits were done.
Detailed ultrastructure studies have been done by other on 
a number of species including the rat (37t 67), the mouse (68), 
man (69), and the dog (68). Electron microscopic examination 
of rabbit adrenal cortex undertaken in this thesis was by no 
means comprehensive. No attempt was made to isolate the three 
cell types of the gland, i.e. the zona glomerulosa, the zona 
fasciculata and the zona reticularis. A comparison of the char­
acteristics of the cell's ultrastructure with the observed char­
acteristics of cells from other species was made. Also, a com-
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Figure 21. Typical carbon monoxide difference spectrum of a microsomal suspension. A) is a baseline spectrum 
while B) is the spectrum of a microsomal prepara­
tion after addition of CO and Sodium dithionite. o
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Table 10
Cytochrome P-^50 determination of microsomal preparations.
Microsomal nmol Cytochrome P-^50/mg proteinPreparation Control ACTH
Ms used with pregn. substrates 0.799 0.792
Ms used in Experiment I 0.736 0.699
Ms used in Experiment II 0.694 0.969
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parison of control and ACTH-stimulated tissue was made. Mito­
chondria in the adrenal cortex varied greatly in size, shape 
and cristae conformation. Shape and cristae conformation have 
been used to identify the different cell types in the adrenal 
cortex of other species (37)- A few elongated mitochondria 
were observed in control rabbit adrenal tissue in Plate 1.
The cristae of these mitochondria were tubular. No mitochondria 
with entirely vesicular cristae were observed in the rabbit 
adrenal tissue studied. Plate 2 shows a section of ACTH-stim­
ulated adrenal cortex in which the mitochodria contain both 
vesicular and tubular cristae. Most of the mitochondria observed 
in these electron micrograph examinations were ovoid with tubular 
or tubulovesicular cristae which are characteristic of the 
zona reticularis.
Densely packed mitochondria and numerous smooth endoplasmic 
reticulum are seen in Plate 2 which is an electron micrograph 
of adrenal tissue from an ACTH-treated rabbit. An electron 
micrograph of a control tissue is shown in Plate 3» Mitochon­
dria are slightly less numerous and smooth endoplasmic reticulum 
are fewer and less dilated.
A prominent feature of the adrenal cortex ultrastructure 
is the appearance of lipid droplets of many sizes and electron 
densities. All electron micrographs showed at least some lipid 
content. Some cells had a particularily abundant number of 
lipid droplets such as can be seen in Plates 4 and 5 which are 
control tissue. Tissue from ACTH-stimulated rabbits showed 
less lipid as seen in Plates 6 and 7* The cells in Plate 7 
appeared quite compact, which is also a characteristic of ACTH
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Plate 1. Electron micrograph of adrenal tissue from a
control rabbit. Magnification x 25,800.
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Plate 2. Electron micrograph of adrenal tissue from an
ACTH-treated rabbit. Magnification x 16,800.
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Plate 3 . Electron micrograph of adrenal tissue from a
control rabbit. Magnification x 16,800,
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Plate 4. Electron micrograph of adrenal tissue from
a control rabbit. Magnification x 10,800,
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Plate 5* Electron micrograph of adrenal tissue from a
control rabbit. Magnification x 16,800.
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Plate 6. Electron micrograph of adrenal tissue from
an ACTH-treated rabbit. Magnification x 16,800.
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Plate /. Electron micrograph of adrenal tissue from an
ACTH-treated rabbit. Magnification x 10,800.
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stimulated cells.
Other characteristics of adrenal cells from ACTH-stimulated 
rabbits were the greater number of prominent Golgi bodies repre­
sented in Plates 5 and 6. Dense whorled bodies such as seen 
in the lipid droplet in the lower left comer of Plate 8 were 
common in control tissue.
In summary the electron micrographs of the adrenal tissue 
from control and ACTH-treated rabbits showed a great variety of 
mitochondrial size, shape and cristae conformation. Most of the 
mitochondria observed had the characteristics of the zona ret­
icularis •
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Plate 8. Electron micrograph of adrenal tissue from
a control rabbit. Magnification x 25»800.
CHAPTER VI 
DISCUSSION
The alteration of the ratio of corticosterone to cortisol 
production, i.e. decrease in croticosterone production with 
concomitant increase in cortisol production, in adrenal cortex 
tissue which has been subjected to prolonged ACTH stimulation 
may play a role in the adaptation of the corticosterone-pro­
ducing animal to long-term stress. Since cortisol is a more 
potent glucocorticoid than corticosterone, its production would 
be more economical to the stressed animal because less of the 
hormone is required for the necessary adaptive physiological 
responses. The exact mechnism of this endproduct ratio-altering 
effect of ACTH has not been determined. The initial divergent 
point of the biosynthetic pathway of the glucocorticoids is a 
logical location for modification of ACTH. In the adrenal 
cortex this point is the conversion of pregnenolone to either 
progesterone by the 33-hydroxysteroid dehydrogenase enzyme 
complex, which leads principally to corticosterone production, 
or to l?a-hydroxypregnenolone by the l?a-hydroxylase system, 
thich leads to cortisol production (Figure 6). Previous studies 
have demonstrated that l?a-hydroxylase activity is increased 
in ACTH-stimulated adrenal tissue (42,51)* The mechanism by 
which lya-hydroxylase is stimulated by ACTH has not been elu­
cidated. Since lya-hydroxylase competes for substrate with 
3^-hydroxySteroid dehydrogenase, affinity for substrate as 
possibly indicated by relative values may be important in 
this competition between enzymes. The apparent Kj.. of l?a-
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hydroxylase for the pregnenolone substrate in ACTH-stimulated 
rabbit adrenal microsomes has been determined to be lower 
than the apparent Kj, of 33-hydroxysteroid dehydrogenase for 
pregnenolone (64). Increased synthesis of l?a-hydroxylase 
of removal of an inhibition of the enzyme already present would 
be required for l?ci-hydroxylase activity to exceed 3^-hydroxy- 
steroid dehydrogenase activity* However, 17^-hydroxylation 
is nearly absent in normal rabbit tissue (16). Another con­
tributing factor to the stimulation of 17a-hydroxylastion may 
be an inhibition of the pregnenolone to progesterone conversion. 
At nonphysiological concentrations cyclic Al«îP, a known mediator 
of ACTH effects, has been shown to inhibit 3 3-hydroxys t ero id 
dehydrogenase actvity (52,53)* If ACTH does inhibit 3^-hydroxy- 
steroid dehydrogenase under physiological conditions, more 
pregnenolone could be 17û-hydroxylated. The 17ci-hydroxypregn- 
enolone to 17<%-hydroxyprogesterone conversion might be expected 
to be affected less because it is required for cortisol produc­
tion (Figure 6). This would necessitate, presumably, the pre­
sence of two 3^-hydroxysteroid dehydrogenases, one specific 
for pregnenolone and the other specific for 170L-hydroxypregnen- 
olone. The effect of ACTH-stimulation on both the pregnenolone 
to progesterone conversion and the 17Q>-hydroxypregnenolone to 
17oC“hydroxyprogesterone conversion has been the main subject 
of investigation of this thesis and will be discussed first.
The 3 ̂-hydroxys t ero id dehydrogenase assay which used preg­
nenolone as a substrate showed that the substrate concentrations 
were saturating as expected (64). A maximal rate of about 
23 nmol per minute per mg protein was observed with both con­
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trol and ACTH-stimulated microsomes. Good agreement of values 
were obtained when control tissues were used v/ith either radio­
active and nonlabelled substrates. Values obtained using the 
microsomes from ACTH-treated rabbits with radioactive substrate 
agreed well with the control values. The rate of progesterone 
formation from nonradio active pregnenolone by the microsomes 
from ACTK-trated rabbits as measured by the radioimmunoassay 
technique was higher at the 20 nmol substrate level than the 
rate obtained with radioactive substrate (Table 3)» Increased 
pregnenolone production is a primary effect of ACTH stimulation 
(4^) but previous gas-liquid chromatographic quantification 
studies have suggested that no significant endogenous pregnen­
olone is present in the rabbit microsomal preparations (64).
If it is assumed, however, that the difference in the amount 
of progesterone product found in the assays using radioactive 
substrate and nonradioactive substrate with microsomes from 
ACTH-stimulated rabbit adrenals at the 20 nmol substrate level 
was due to the presence of endogenous pregnenolone, it can 
be calculated that the microsomal suspension should have con­
tained 14.2 nmol of endogenous pregnenolone per ml of suspen­
sion. Therefore, the substrate amount with the addition of 
20 nmol of exogenous pregnenolone should have been 3^*2 nmol. 
Since values obtained by the radioactive and the radioimmuno­
assay methods agreed, it might be assumed that the rate values 
for the control microsomes are accurate. In this case a rate 
of 39*0 nmol per minute per mg protein at a substrate level 
of 34.2 nmol would require that the specific activity of the
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enzyme in the microsomal preparation from ACTH-stimulated rabbits 
be double that in the control preparations• However, a rate 
of 12.3 nmol per minute per mg protein was obtained for the 
microsomes from ACTH-treated animals with nonradioactive sub­
strate at the 50 nmol substrate level. The sum of endogenous and 
exogenous substrate might be expected to be 64.2 nmol which 
should yield an initial rate of 64.5 nmol per minute per mg 
protein, if the specific activity of the 3^-hydroxysteroid 
dehydrogenase in this preparation was twice that of the control 
preparation. Since the amount of progesterone was no higher 
in the zero time incubations of the microsomes from ACTH-treated 
rabbits than the zero time values for the control microsomes, 
it appears that no greater initial product inhibition could 
have been present in the microsomes from ACTH trated animals 
than in the microsomes from control animals. In conclusion 
no consistent difference in the rate of conversion of pregnen­
olone to progesterone appeared observable in microsomes from 
control and ACTH-stimulated rabbits and no clear reason can be 
suggested for the aberrant results for the microsomes from 
ACTH-stimulated adrenals obtained by radioimmunoassay techni­
ques.
The same substrate concentrations used for the pregnen­
olone substrate studies did not appear to be saturating for 
the 3P-hydroxysteroid dehydrogenase enzyme in the l?a-hydroxy- 
pregnenolone substrate studies. It was questionable whether 
there was adequate ACTH stimulation in the Experiment I micro­
somal preparations. Adrenal weights did not increase for the 
ACTH-injected rabbits and l?a-hydroxylase activity was only
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slightly higher for the ACTH-stimulated tissue. The rates of 
33-hydroxysteroid dehydrogenation in the assay of Experiment I 
were equivalent for both control and ACTH-stimulated tissue. 
Apparent values for microsomes from control and ACTH-
stimulated rabbits were 161 and 222 nmol per minute per mg 
protein# respectively. Apparent values were 2.10 x 10”^ M 
for microsomes from control adrenals and 2.31 x 10  ̂H for micro­
somes from ACTH-stimulated adrenals. Evidence of ACTH stimula­
tion in the microsomal preparations used in Experiment II was
1^good in that the rate of l?a-hydroxy(4- C)pregnenolone formation 
from (4- C)pregnenolone was 10 fold higher in the tissue from 
ACTH-treated rabbits than in the control tissue. The rates 
of lya-hydroxyprogesterone formation from l?a-hydroxypregnenolone 
at the 30 nmol substrate level with both ^H-labelled and non­
radioactive substrate showed that the values obtained using 
the microsomes from ACTH-stimulated rabbits were lower than 
those obtained using the control microsomes. However, rates 
were equal for both preparations at the 20 nmol nonradioactive 
substrate level. In addition, comparison of rates obtained with 
radioactive substrate and with nonradioactive substrate at the 
50 nmol amount showed equivalent values for each microsomal 
preparation. These results suggest the absence of endogenous 
substrate. The apparent V,̂  values for the microsomes from
IViSLX
control and ACTH-treated rabbits of Experiment II were I89 and 
59 nmol per minute per mg protein, respectively. Apparent Kĵ  
values were 2.59 x 10 K for the control microsomes and 0.28 x 
10”^ M for the microsomes from ACTH-stimulate adrenals. In 
Experiment II the increase of substrate level from 20 to 50
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nmol had less effect on the rate than for the control micro­
somes. Consequently, the rates obtained for the microsomes from 
ACTH-stimulated rabbits yielded a double reciprocal Lineweaver- 
Burke plot with a lower slope than for the control microsomes. 
Since only two substrate concentrations were used, it is possi­
ble that the slope obtained for the microsomes from ACTH-stimu­
lated rabbits caused an underestimation of the apparent kinetic 
values. Admittedly the accuracy of all the apparent kinetic 
values is in doubt because they were calculated from only two 
substrate concentrations. In comparison the apparent and 
for the pregnenolone substrate have been measured to be 
6.48 X 10"^ M and 121 nmol per minute per mg protein in micro­
somes from ACTH-stimulated rabbit adrenals (64). In addition, 
apparent values for the pregnenolone substrate in nonstim­
ulated microsmes from other species and other steroid-synthe-
—6sizing tissue have been measured to be 0.81 x 10" M for rat 
adrenal tissue (?1), 2.6 x 10"^ M for porcine ovarian tissue 
(72) and 3 x lO"^ U for bovine adrenals (22). These apparent 
values of the 3^-hydroxysteroid dehydrogenase enzyme for the 
pregnenolone substrate compared to the relatively higher appa­
rent obtained for the 17oc-hydroxypregnenolone substrate in 
the present studies suggest that pregnenolone is the preferred 
substrate over 17tt-hydroxypregnenolone in rabbit adrenal micro­
somes .
The use of serum in some of the incubations containing 
50 nmol of substrate caused an increased rate of 3^-hydroxy- 
steroid dehydrogenation by both tissues. This stimulation 
may be caused by the prevention of product inhibition. Pro-
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duct would be removed by binding of the l?a-hydroxyprogesterone 
to the serum proteins. It should be noted that normal human 
serum contains little l?a-hydroxypregnenolone and would not add 
significantly to substrate concentrations (73)* Product inhibi­
tion, therefore, appears to have been present in both control 
and ACTH-stimulated microsomal preparation assays. Product 
inhibition for the microsomes from ACTH-stimulated rabbits appea­
red greater because the rates at the 50 nmol level of labelled 
and nonlabelled 17a-hydroxypregnenolone were lower than those 
for the control microsomes (Table 7)* In the experiments using 
50 nmol of nonradioactive substrate plus serum, virtually the 
same maximun rate was observed with both types of microsomal 
preparations. The rate of 33-bydroxysteroid dehydrogenation 
for the control microsomes incubated with serum increased 10^
' over the rate for control microsomes not incubated with serum.
On the other hand the rate for the microsomes from ACTH-stimu­
lated rabbits incubated with serum increased 20^ over the rate 
obtained in the absence of serum. These results may suggest 
that ACTH increases the sensitivity of the enzyme to product 
inhibition.
Differences in the rates of product formation for the 
substrates pregnenolone and 17oc-hydroxypregnenolone have been 
demonstrated in the described 3^-hydroxysteroid dehydrogenase 
assays. Confirmation of these results may require that the 
reaction rates with each substrate be measured in the same 
tissue to insure constant conditions. Product inhibition was 
not investigated in the pregnenolone substrate assays and may 
have been the cause of the lower rates obtained for 3P-hydroxy-
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steroid dehydrogenase activity with pregnenolone. If the lower 
rates were a result of product inhibition, progesterone would 
appear to cause a greater inhibition than l?a-hydroxyprogesterone. 
Protesterone has been reported to inhibit 3 P -hydr oxys t ero id dehy­
drogenase activity (29). As pregnenolone formation is rate- 
limiting in steroid hormone biosynthesis and is increased by 
ACTH stimulation, the formation of progesterone is also incre­
ased due to increased substrate concentration for the 3^-hydroxy- 
steroid dehydrogenase enzyme. This concentration may reach a 
level in which the conversion is substantially inhibited by pro­
duct. The accumulating pregnenolone could be diverted then to 
the l?a-hydroxylase which has been shown to have a lower apparent 
for pregnenolone than does the 3 P -hydroxys t ero id dehydrogenase 
in stimulated tissue. The conversion of 17tt-hydroxypregnenol- 
one to l?a-hydroxyprogesterone and the subsequent conversions 
leading tocortisol formation would have to take place unaffe­
cted by the inhibiting influence of progesterone. The exist­
ence of more than one enzyme form, each with its own substrate 
specificity could allow for this. Any inhibitory effect of 
ACTH in the intact tissue on the two conversions studied may 
well be the consequence of increased pregnenolone production and 
not the direct inhibition of the 3P-hydroxysteroid dehydrogenase 
by the hormone. From a comparison of the results of the assays 
with labelled and nonlabelled substrate, there appeared to be no 
increased steroid (product or substrate) in the washed micro­
somes which might have invalidated the measurement of rates, 
especially with the use of radioactive substrate.
The stimulation of 17a-hydroxylase activity does not depend
Ü9
wholly on the inhibition of 3^“hydroxysteroid dehydrogenase.
The lower apparent values of 17 a-hydroxylase for pregnenolone 
compaxed with the apparent of 3^-hydroxysteroid dehydroge­
nase for the same substrate in ACTH-stimulated tissue (64) 
could explain the greater formation of 17a-hydroxycorticosteroids. 
Protein synthesis is thought to be required for increased l?a- 
hydroxylase activity in that cyclohexaraide decreases 17<i-hydro xy- 
corticosteroid production in ACTH-treated rabbits (16). The 
reason for measuring the cytochrome P-450 which is a component 
of l?tt-hydroxylase enzyme system was to determine whether this 
component is increased by ACTH stimulation. However, levels 
of the cytochrome were in general slightly less in microsomes 
from ACTH-treated rabbits than in control microsomes. Similar 
results were obtained in previous studies (64). The exception 
was the level of cytochrome measured in microsomes from ACTH- 
treated rabbits in Experiment II. Stimulation in this tissue 
was greater than that of the microsomal preparation of Experiment
I. Increased mitochondrial size and fragility have been reported 
to occur with ACTH-stimulation (37,68). It is possible that 
homogenization of adrenal tissue could fragment some of the 
fragile mitochondria and cause them to sediment with the micro­
somes. The mitochondrial fragments which are known to contain 
a higher specific activity of cytochrome P-450 (?4) than micro­
somes from adrenal tissue may have contributed significantly 
to the cytochrome levels and may have been the cause of the 
increase compared to the control and other ACTH-stimulated tis­
sue. These results do not deny necessarily an increased synthe­
sis of the 17ot-bydroxylase component but do indicate that the
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cytochrome may not be a rate-limiting factor in l?a-hydroxyla- 
tion activity (64).
The electron microscopic examination of the adrenal tissue 
from control and ACTH-treated rabbits showed a number of charac­
teristics observable in other species (37»68,69,70,71). The 
great variety of mitochondrial size, shape and cristae found 
in other species (37) was evident. These features have been 
used in other species to identify cell types (37)- Iri general 
the mitochondria of the zona glomerulosa have been found to 
be elongated and to possess either tubular or laminar cristae 
(37) • All species studied to date have vesicular cristae in 
the mitochondria of their zona fasciculata cells (37»67,68,69# 
70). The shape of fasciculata mitochondria is usually ovoid 
while the zona reticularis of most species contains ovoid mito­
chondria with tubular or tubulovesicular cristae (37)' Since 
most of the mitochondria in the electron micrographs were ovoid 
with tubular or tubulovesicular cristae, it might be thought that 
the cells were from the zona reticularis.
Comparison of control and ACTH-stimulated tissue in prev­
ious studies of other species have revealed increases in the 
number of mitochondria and smooth endoplasmic reticulum in the 
zona fasciculata and reticularis cells with a sharp decrease 
in lipid droplets (37,68). Mitochondria were more densely packed 
in the tissue from ACTH-stimulated rabbits and smoooth endoplas­
mic reticulum were somewhat more abundant. The compactness of 
some of the cells of the ACTH-stimulated tissue has been noted 
before and may be a result of lipid depletion (68), The appear­
ance of dense whorled bodies which have been identified in other
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studies as myelin bodies (37) are knov/n to be more apparent 
completely unstimulated tissue (37)# These signs of stimulation 
can not be considered positive indications of stimulations beca­
use cell types were not identified. These observations of the 
electron micrographs of the rabbit adrenal tissue support the 
biochemical evidence of stimulation of the ACTH-treated adrenals.
CHAPTER VII 
smmRY
1. 3^“Hydroxysterold dehydrogenase activity was determined
by measuring the rate of progesterone formation from preg­
nenolone, Microsomal suspensions from control and ACTH- 
treated rabbit adrenals were incubated with ^^C-labelled 
and nonlabelled pregnenolone in the presence of KAD* cofac­
tor. The substrate concentrations appeared saturating and 
yielded a maximal rate of about Z3 nmol per minute per mg 
protein. Agreement of values obtained with radioactive 
substrate and with nonradioactive substrate was good for the 
control microsomes. Results for the 33“hydroxysteroid 
dehydrogenase assay using microsomes from ACTH-treated rab­
bit adrenals with ^^C-labelled substrate agreed well with 
the control values. However, rate values for microsomes 
from ACTH-treated tissue with nonradioactive pregnenolone 
were 39*0 nmol per minute per mg protein atthe 20 nmol subst­
rate level and 12.0 nmol per minute per mg protein at the 
50 nmol substrate level. These anomolous results could not 
be explained by either increased endogenous substrate or 
by increased enzyme specific activity in the microsomes 
from ACTH-stimulated adrenals.
2. l?a-Hydroxylase assays were done on the two microsomal prep­
arations which were used in the 17^-hydroxylase activity 
was only three fold higher than that found in the control 
microsomes. Experiment 11 employed two ACTH preparations.
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one more pure than the other. The degree of stimulation 
as determined by the l?a-hydroxylase assay of the microsomes 
from ACTH-treated adrenals was about 10 fold greater than 
the controls and was comparable for both ACTH preparations.
3- 33“Hydroxysteroid dehydrogenase assays of microsomes from
control and ACTH-stimulated rabbit adrenals with -̂ Ĥ-labelled 
and nonlabelled 17a-hydroxypregnenolone substrate showed 
that the substrate amounts of 20 and 50 nmol were not sat­
urating for the enzyme as they were in the pregnenolone 
substrate studies. Rate values for Experiment I in which 
less stimulation of adrenal tissue by ACTH were equivalent 
for both tissues. Rates at the 20 nmol level were 53*1 
and 4y.6 nmol per minute per mg protein for microsomes from 
control and ACTH-treated rabbits, respectively. Rates at 
the 50 nmol substrate level were 8?.6 and 90.I nmol per 
minute per mg protein for control and ACTH-stimulated micro­
somes from control and ACTH-treated rabbits at the 20 nmol 
substrate level. Lower rates were observed for the micro­
somes from ACTH-stimulated rabbits at the 50 nmol substrate 
level than for the control tissue, being 89.7 and 59*1 nmol 
per minute per mg protein, respectively (values obtained 
using nonradioactive substrate). Rate values using radio­
active substrate agree well with these values and were 
73*2 and 52.0 nmol per minute per mg protein for microsomes 
from control and ACTH-treated tissues. Apparent and
Kje values for the 3^-hydroxysteroid dehydrogenase for 17^- 
hydroxypregnenolone substrate were 161 nmol per minute
9^
per mg protein and 2,10 x 10"^ M for the microsomes from 
control tissue. For the microsomes from ACTH-treated rabbits 
the apparent and values for the 3P-hydroxysteroid
dehydrogenase enzyme were 222 nmol per minute per mg protein 
and 2.31 x 10”^ M, respectively.
4. Human serum addition to some of the 3^-hydroxysteroid dehyd­
rogenase incubations increased the enzyme activity in both 
tissues at the 50 nmol substrate level. A 20^ increase in 
the 3P“Hydroxysteroid dehydrogenase activity was observed 
for the microsomes from ACTH-stimulated rabbits while only
a 10% increase was observed for the control microsomes.
These results suggest that ACTH increased the sensitivity 
of the 3^“Hydroxysteroid deHydrogenase enzyme to product 
inhibition.
5. Comparison of the rates of 3P“Hydroxysteroid dehydrogenase 
activity with the pregnenolone substrate (maximal rate 
obtained ablut 23 nmol per minute per mg protein) and with 
the 17a-hydroxypregnenolone substrate (maximal rate obtained 
about 90 nmol per minute per mg protein) showed higher rates 
with 17tthydroxypregnenolone substrate. It is possible that 
product inhibition was responsible for the lower rates obtained 
with the pregnenolone substrate. Apparent values for
the 3^“Hydroxysteroid dehydrogenase enzyme with the 1?^- 
hydroxypregnenolone substrate were of the order of 10~^
K. Apparent Kp for the enzyme with the pregnenolone sub­
strate had been previously determined to be of the order 
of 10 ^ M. Relative values indicate pregnenolone to 
be the favored substrate in rabbit adrenal tissue.
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6. Cytochrome P-450 levels were measured in microsomes from 
control and ACTH-treated rabbit adrenals. In general, 
levels obtained in microsomes from ACTH-stimulated adrenals 
were slightly lower than those obtained for the control 
tissue. This result agreed with previous determinations.
An exception was the microsomal preparation which showed 
the highest degree of stimulation by ACTH as determined by 
170c-hydroxylase activity. The level of cytochrome P-^gO 
was greater in this prepairation than in the control prepar­
ations. Cytochrome P-450 may not be a rate-limiting com­
ponent of the 170c-hydroxylase system.
7. Electron microscopic examinations of adrenal tissue from 
control and ACTH-stimulated adrenal tissue revealed a great 
variety of mitochondrial size, shape and cristae as have 
been observed in other species. The presence of fewer lipid 
droplets and more smooth endoplasmic reticulum in the tis­
sue from ACTH-treated rabbit adrenal tissue supported the 
biochemical evidence of stimulation of the tissue by ACTH.
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